Loading: 100%
IMMUNOGEN INC logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 308 (as per FY 2016)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker IMGNno data available
Financial year endsFY ends End of Juneno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,02,55,07,510,0
datesClosing price (adj.)
13.10.20175.97
11.10.20176.62
04.10.20177.83
27.09.20177.31
20.09.20176.53
13.09.20177.07
06.09.20177.24
30.08.20178.47
23.08.20176.57
16.08.20176.12
09.08.20175.74
02.08.20175.49
26.07.20176.19
19.07.20175.96
12.07.20176.92
05.07.20177.30
27.06.20176.54
20.06.20175.42
13.06.20174.64
06.06.20174.78
30.05.20174.88
23.05.20174.98
16.05.20174.86
09.05.20173.96
02.05.20174.29
25.04.20174.33
18.04.20173.24
11.04.20172.89
04.04.20173.71
28.03.20173.79
21.03.20173.61
14.03.20173.88
07.03.20173.31
28.02.20173.40
21.02.20172.47
14.02.20172.45
07.02.20172.38
31.01.20172.34
24.01.20172.51
17.01.20172.56
10.01.20172.51
03.01.20172.08
27.12.20161.64
19.12.20161.69
12.12.20161.76
05.12.20162.00
28.11.20161.86
21.11.20162.08
14.11.20162.14
07.11.20161.66
31.10.20161.82
24.10.20162.27
17.10.20162.31
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
5.97n/a
Market Capitalisation
in million USD
521n/a
Enterprise Value
in million USD
383n/a
Common Shares Outstanding
as per Jun 30, 2016
87,209,000n/a
Preferred Shares Outstanding
as per Jun 30, 2016
n/a
Average Basic Shares Outstanding
TTM
86,976,000n/a
Average Diluted Shares Outstanding
TTM
n/a
Index Membership
n/a
Business Summary
Immunogen Inc is a clinical-stage biotechnology company that develops targeted anticancer therapeutics. It has developed its ADC technology to enable the creation of anticancer products.
no data available
Key Financials & Ratios (all figures TTM as per , million USD, full statements further below)
Profit & Loss
Revenues 0n/a
Gross Profit 0n/a
Operating Income 0n/a
EBITDA 0n/a
Net Profit 0n/a
Balance Sheet
Cash and Cash Equivalents 245n/a
Receivables 1n/a
Total Current Assets 255n/a
PP&E 23n/a
Total Assets 287n/a
Accounts Payable 12n/a
Current Debt 1n/a
Total Current Liabilities 61n/a
Long-Term Debt 106n/a
Total Liabilities 369n/a
Total Equity -82n/a
Cash Flow
Depreciation & Amortisation 5n/a
Change in Working Capital -2n/a
Operating Cash Flow -125n/a
Net Change in PP&E and Intangibles -10n/a
Investing Cash Flow -10n/a
Dividends Paid 0n/a
Financing Cash Flow 102n/a
Total Change in Cash -33n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 0.0%n/a
Operating Margin 0.0%n/a
Net Profit Margin 0.0%n/a
Return on Equity 0.0%n/a
Return on Assets 0.0%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share -0.95n/a
FCF per Share n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value -6.31n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales n/a
Book to Market Value -0.16n/a
Other Ratios
Current Ratio 414.7%n/a
Liabilities to Equity Ratio -448.8%n/a
Debt to Assets Ratio 37.3%n/a
Profit & Loss StatementP&L data quality: 44% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
14
19
16
36
60
86
60
Sales & Services Revenue
0
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
0
Cost of revenue
0
0
0
0
0
0
0
Cost of Goods & Services
0
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
0
Gross Profit
14
19
16
36
60
86
60
Other Operating Income
0
0
0
0
0
0
0
Operating Expenses
-65
-79
-90
-109
-131
-140
-185
Selling, General & Administrative
-15
-16
-20
-21
-24
-28
-37
Selling & Marketing
0
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
0
Research & Development
-50
-63
-69
-87
-107
-112
-148
Depreciation & Amortization
0
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
0
Operating Income (Loss)
-51
-60
-73
-73
-72
-54
-125
Non-Operating Income (Loss)
0
2
0
0
0
-1
0
Interest Expense, net
0
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
2
0
0
0
-1
0
Pretax Income (Loss), Adjusted
-51
-58
-73
-73
-71
-55
-125
Abnormal Gains (Losses)
0
0
0
0
0
5
20
Acquired In-Process R&D
0
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
0
Pretax Income (Loss)
-51
-58
-73
-73
-71
-50
-105
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-51
-58
-73
-73
-71
-50
-105
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-51
-58
-73
-73
-71
-50
-105
Minority Interest
0
0
0
0
0
0
0
Net Income
-51
-58
-73
-73
-71
-50
-105
Preferred Dividends
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Net Income Available to Common Shareholders
-51
-58
-73
-73
-71
-50
-105
Remarks
restated on Aug 29, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Aug 28, 2014 n/a
calculated values,
restated on Aug 27, 2015 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
Balance SheetBS data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
191
161
195
142
278
245
Cash & Cash Equivalents
n/a
191
161
195
142
278
245
Short Term Investments
n/a
0
0
0
0
0
0
Accounts & Notes Receivable
n/a
5
0
0
2
5
1
Accounts Receivable, Net
n/a
5
0
0
2
5
1
Notes Receivable, Net
n/a
0
0
0
0
0
0
Unbilled Revenues
n/a
0
0
0
0
0
0
Inventories
n/a
0
1
1
3
3
1
Raw Materials
n/a
0
0
0
0
0
0
Work In Process
n/a
0
0
0
0
0
0
Finished Goods
n/a
0
0
0
0
0
0
Other Inventory
n/a
0
0
0
0
0
0
Other Short Term Assets
n/a
5
4
5
4
6
8
Prepaid Expenses
n/a
3
2
3
2
4
5
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Assets Held-for-Sale
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Income Taxes Receivable
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Miscellaneous Short Term Assets
n/a
3
2
2
1
2
3
Total Current Assets
n/a
202
166
201
151
292
255
Property, Plant & Equipment, Net
n/a
13
12
11
14
16
23
Property, Plant & Equipment
n/a
0
0
0
0
0
0
Accumulated Depreciation
n/a
0
0
0
0
0
0
Long Term Investments & Receivables
n/a
0
0
0
0
0
0
Long Term Investments
n/a
0
0
0
0
0
0
Long Term Marketable Securities
n/a
0
0
0
0
0
0
Long Term Receivables
n/a
0
0
0
0
0
0
Other Long Term Assets
n/a
3
2
2
0
5
10
Intangible Assets
n/a
0
0
0
0
0
0
Goodwill
n/a
0
0
0
0
0
0
Other Intangible Assets
n/a
0
0
0
0
0
0
Prepaid Expense
n/a
0
0
0
0
0
0
Deferred Tax Assets
n/a
0
0
0
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
0
0
0
Prepaid Pension Costs
n/a
0
0
0
0
0
0
Discontinued Operations
n/a
0
0
0
0
0
0
Investments in Affiliates
n/a
0
0
0
0
0
0
Miscellaneous Long Term Assets
n/a
3
2
2
0
5
10
Total Noncurrent Assets
n/a
16
14
13
15
22
32
Total Assets
n/a
218
180
214
165
314
287
Liabilities and owners' equity
Payables & Accruals
n/a
11 11241000
13 12926000
17 16700000
18 18352000
27 26925000
32 31947000
Accounts Payable
n/a
3 3213000
3 3395000
4 4498000
5 4819000
8 8138000
12 11510000
Accrued Taxes
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
n/a
8 8028000
10 9531000
12 12202000
14 13533000
19 18787000
20 20437000
Short Term Debt
n/a
1 979000
1 979000
1 979000
1 528000
1 646000
1 772000
Short Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
n/a
2 2346000
2 2349000
1 1494000
2 2374000
8 8239000
29 28720000
Deferred Revenue
n/a
2 2346000
2 2349000
1 1494000
2 2374000
0 333000
14 13582000
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
0 0
0 0
0 0
0 0
8 7906000
15 15138000
Total Current Liabilities
n/a
15 14566000
16 16254000
19 19173000
21 21254000
36 35810000
61 61439000
Long Term Debt
n/a
8 7583000
7 6605000
6 5626000
6 5679000
6 6301000
106 106236000
Long Term Borrowings
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
n/a
56 55523000
74 73559000
67 66950000
63 62686000
237 236608000
202 201714000
Accrued Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
n/a
52 51545000
70 69761000
63 63384000
59 58969000
41 40855000
19 19288000
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
4 3978000
4 3798000
4 3566000
4 3717000
196 195753000
182 182426000
Total Noncurrent Liabilities
n/a
63 63106000
80 80164000
73 72576000
68 68365000
243 242909000
308 307950000
Total Liabilities
n/a
78 77672000
96 96418000
92 91749000
90 89619000
279 278719000
369 369389000
Preferred Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
571 570606000
588 587846000
699 698614000
724 723830000
744 743974000
771 771383000
Common Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Retained Earnings
n/a
-431 -430637000
-504 -503956000
-577 -576767000
-648 -648131000
-709 -708870000
-854 -853687000
Other Equity
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Equity Before Minority Interest
n/a
140 139969000
84 83890000
122 121847000
76 75699000
35 35104000
-82 -82304000
Minority Interest
n/a
0 0
0 0
0 0
0 0
0 0
0 0
Total Equity
n/a
140 139969000
84 83890000
122 121847000
76 75699000
35 35104000
-82 -82304000
Total Liabilities & Equity
n/a
218 217641000
180 180308000
214 213596000
165 165318000
314 313823000
287 287085000
Remarks restated on n/a restated on Aug 29, 2012 n/a restated on Aug 29, 2013 n/a restated on Aug 28, 2014 n/a restated on Aug 27, 2015 n/a restated on Aug 25, 2016 n/a restated on Aug 25, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '10FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-51
-58
-73
-73
-71
-61
-145
Net Income
0
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
0
Depreciation & Amortization
5
5
5
5
5
6
5
Non-Cash Items
4
6
11
13
31
16
17
Stock-Based Compensation
0
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
0
Change in Working Capital
1
40
23
-5
-19
-17
-2
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
0
Cash from Operating Activities
-41
-8
-34
-60
-54
-57
-125
Change in Fixed Assets & Intangibles
-2
-2
-3
-4
-8
-7
-10
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
0
Net Change in Long Term Investment
1
1
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
1
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
0
Cash from Investing Activities
-1
-1
-3
-4
-8
-6
-10
Dividends Paid
0
0
0
0
0
0
0
Cash From (Repayment of) Debt
0
0
0
0
0
0
97
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
0
Cash From (Repurchase of) Equity
81
91
7
98
9
4
5
Increase in Capital Stock
81
91
7
98
9
4
5
Decrease in Capital Stock
0
0
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
194
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
0
Cash from Financing Activities
81
91
7
98
9
199
102
Net Cash Before Disc. Operations and FX
40
82
-30
34
-53
136
-33
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
0
Net Cash Before FX
40
82
-30
34
-53
136
-33
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
Net Changes in Cash
40
82
-30
34
-53
136
-33
Remarks
restated on Aug 29, 2012 n/a
calculated values,
restated on Aug 29, 2013 n/a
calculated values,
restated on Aug 28, 2014 n/a
calculated values,
restated on Aug 27, 2015 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
restated on Aug 25, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo